Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval
- Written by PR Newswire
NEW YORK, March 24, 2025 /PRNewswire/ -- On March 17, 2025, US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical—an innovative biopharmaceutical company incubated by Beijing Hotgen Biotech Co., Ltd. (SH.688068)—received Fast Track Designation from the United States Food and...
